Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis

Clin Vaccine Immunol. 2009 Dec;16(12):1844-6. doi: 10.1128/CVI.00268-09. Epub 2009 Sep 30.

Abstract

We compared a lateral flow device to galactomannan and (1-->3)-beta-D-glucan assays to detect invasive aspergillosis in an established guinea pig model of pulmonary disease. The lateral flow device became positive earlier (day 3) than the (1-->3)-beta-D-glucan and galactomannan assays (day 5), with all samples positive by each assay on day 7.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Fungal / analysis*
  • Antigens, Fungal / immunology
  • Aspergillus / immunology
  • Aspergillus / isolation & purification*
  • Biomarkers / analysis
  • Chromatography, Liquid / instrumentation
  • Galactose / analogs & derivatives
  • Guinea Pigs
  • Immunoassay / instrumentation
  • Invasive Pulmonary Aspergillosis / diagnosis*
  • Invasive Pulmonary Aspergillosis / immunology
  • Male
  • Mannans / analysis*
  • Mannans / immunology
  • Point-of-Care Systems
  • Proteoglycans
  • Sensitivity and Specificity
  • beta-Glucans / analysis*
  • beta-Glucans / immunology

Substances

  • Antigens, Fungal
  • Biomarkers
  • Mannans
  • Proteoglycans
  • beta-Glucans
  • galactomannan
  • polysaccharide-K
  • Galactose